Search research articles
Contact Us
Filters
Showing results (51-60 of 323) with videos related to
Page
of 33
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
September 24, 2024
Duration of immunotherapy in dMMR/MSI-H metastatic colorectal cancer patients
Ofer Margalit, Amos Stemmer, William J Chapin, et al.
Critical Reviews in Oncology/Hematology
|
June 20, 2015
First-line anti-EGFR monoclonal antibodies in panRAS wild-type metastatic colorectal cancer: A systematic review and meta-analysis
Filippo Pietrantonio, Chiara Cremolini, Fausto Petrelli, et al.
Pathology, Research and Practice
|
January 26, 2024
Claudin-18.2 testing and its impact in the therapeutic management of patients with gastric and gastroesophageal adenocarcinomas: A literature review with expert opinion
Valentina Angerilli, Filippo Ghelardi, Floriana Nappo, et al.
JAMA Oncology
|
December 8, 2022
Effectiveness of Immune Checkpoint Inhibitors in Patients With Advanced Esophageal Squamous Cell Carcinoma: A Meta-analysis Including Low PD-L1 Subgroups
Dominic Wei Ting Yap, Alberto Giovanni Leone, Nicky Zhun Hong Wong, et al.
Pharmacogenomics
|
December 1, 2015
BRAF in metastatic colorectal cancer: the future starts now
Armando Orlandi, Alessandra Calegari, Alessandro Inno, et al.
Tumori
|
October 6, 2020
Validation of the Colon Life nomogram in patients with refractory metastatic colorectal cancer enrolled in the RECOURSE trial
Filippo Pietrantonio, Giovanni Fucà, Paolo Manca, et al.
Therapeutic Advances in Medical Oncology
|
March 4, 2024
Adjuvant and neoadjuvant chemotherapy for MSI early gastric cancer: a systematic review and meta-analysis
Fausto Petrelli, Maria Antista, Francesca Marra, et al.
International Journal of Molecular Sciences
|
November 17, 2019
The Landscape of Actionable Gene Fusions in Colorectal Cancer
Filippo Pagani, Giovanni Randon, Vincenzo Guarini, et al.
Canadian Journal of Diabetes
|
October 11, 2020
Survival of Colorectal Cancer Patients With Diabetes Mellitus: A Meta-Analysis
Fausto Petrelli, Michele Ghidini, Emanuele Rausa, et al.
Clinical Colorectal Cancer
|
February 1, 2022
Final results of the CAVE trial in RAS wild type metastatic colorectal cancer patients treated with cetuximab plus avelumab as rechallenge therapy: Neutrophil to lymphocyte ratio predicts survival
Davide Ciardiello, Vincenzo Famiglietti, Stefania Napolitano, et al.
Page
of 33
Search research articles
Search
Showing results (51-60 of 323) with videos related to
Sort By:
Page
of 33
European Journal of Cancer (Oxford, England : 1990)
|
September 24, 2024
Duration of immunotherapy in dMMR/MSI-H metastatic colorectal cancer patients
Ofer Margalit, Amos Stemmer, William J Chapin, et al.
Critical Reviews in Oncology/Hematology
|
June 20, 2015
First-line anti-EGFR monoclonal antibodies in panRAS wild-type metastatic colorectal cancer: A systematic review and meta-analysis
Filippo Pietrantonio, Chiara Cremolini, Fausto Petrelli, et al.
Pathology, Research and Practice
|
January 26, 2024
Claudin-18.2 testing and its impact in the therapeutic management of patients with gastric and gastroesophageal adenocarcinomas: A literature review with expert opinion
Valentina Angerilli, Filippo Ghelardi, Floriana Nappo, et al.
JAMA Oncology
|
December 8, 2022
Effectiveness of Immune Checkpoint Inhibitors in Patients With Advanced Esophageal Squamous Cell Carcinoma: A Meta-analysis Including Low PD-L1 Subgroups
Dominic Wei Ting Yap, Alberto Giovanni Leone, Nicky Zhun Hong Wong, et al.
Pharmacogenomics
|
December 1, 2015
BRAF in metastatic colorectal cancer: the future starts now
Armando Orlandi, Alessandra Calegari, Alessandro Inno, et al.
Tumori
|
October 6, 2020
Validation of the Colon Life nomogram in patients with refractory metastatic colorectal cancer enrolled in the RECOURSE trial
Filippo Pietrantonio, Giovanni Fucà, Paolo Manca, et al.
Therapeutic Advances in Medical Oncology
|
March 4, 2024
Adjuvant and neoadjuvant chemotherapy for MSI early gastric cancer: a systematic review and meta-analysis
Fausto Petrelli, Maria Antista, Francesca Marra, et al.
International Journal of Molecular Sciences
|
November 17, 2019
The Landscape of Actionable Gene Fusions in Colorectal Cancer
Filippo Pagani, Giovanni Randon, Vincenzo Guarini, et al.
Canadian Journal of Diabetes
|
October 11, 2020
Survival of Colorectal Cancer Patients With Diabetes Mellitus: A Meta-Analysis
Fausto Petrelli, Michele Ghidini, Emanuele Rausa, et al.
Clinical Colorectal Cancer
|
February 1, 2022
Final results of the CAVE trial in RAS wild type metastatic colorectal cancer patients treated with cetuximab plus avelumab as rechallenge therapy: Neutrophil to lymphocyte ratio predicts survival
Davide Ciardiello, Vincenzo Famiglietti, Stefania Napolitano, et al.
Page
of 33